Navigation Links
Tamoxifen trial should prompt breast cancer patients to reconsider treatment options
Date:12/6/2012

MAYWOOD, Il. - A groundbreaking clinical trial involving the breast cancer drug tamoxifen should prompt certain breast cancer patients to reconsider their treatment options, according to Loyola University Medical Center breast cancer specialist Dr. Kathy Albain.

The trial is called ATLAS (Adjuvant Tamoxifen Longer Against Shorter). It included women with estrogen receptor-positive breast cancer that had not spread to distant organs. Women who took tamoxifen for 10 years had a lower risk of recurrence and lower mortality rate than women who took the drug for 5 years, which is the current standard of care.

"I think this is going to create a need for women with this type of breast cancer to readdress their treatment options," Albain said.

Dr. Richard Gray, on behalf of the ATLAS trial investigators, announced results Dec. 5 during the San Antonio Breast Cancer Symposium. Albain moderated the opening oral session in which the results were announced and discussed.

A worldwide team of investigators enrolled 6,846 women with estrogen receptor-positive breast cancer who had been taking tamoxifen for five years and were free of recurrence of their breast cancer. Women were randomly assigned to either stop taking tamoxifen, or to continue taking the drug for another five years.

During the second decade following diagnosis, women who continued taking tamoxifen had a 25 percent lower recurrence rate and a 29 percent lower breast cancer mortality rate, compared with women who stopped after five years. Overall, taking tamoxifen for 10 years cut the risk of dying of breast cancer in half.

Albain noted there are risks to taking tamoxifen, including a higher risk of endometrial cancer in postmenopausal patients and an increased risk of blood clots. But endometrial cancer generally is curable, and in certain women, the benefits of taking tamoxifen for longer periods may outweigh the risks, Albain said.

Premenopausal
'/>"/>

Contact: Jim Ritter
jritter@lumc.edu
708-216-2445
Loyola University Health System
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Possible therapy for tamoxifen resistant breast cancer identified
2. New finding gives clues for overcoming tamoxifen-resistant breast cancer
3. 10 Years of Tamoxifen Better Than 5: Study
4. Brain Tumor Vaccine Shows Promise in Early Trial
5. URMC clinical trial tests new regimen for hypertension
6. Analysis Finds Clinical Trials Often Small, of Poor Quality
7. US spends far more for health care than 12 industrialized nations, but quality varies
8. New Weight-Loss Drug Shows Promise in Trial
9. Palpitations are predictive of future atrial fibrillation
10. Trial Set to See if Drug Can Prevent Alzheimers
11. Experts call for clinical trials to test non-skeletal benefits of vitamin D
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... The 8th Annual Paint Columbus Pink® is a series ... Pooch Contest, Light of Life Ceremony, Power in Prayer, Bright ... – all in support of cancer awareness. , Paint Columbus ... Columbus Pink Foam and Obstacle Challenge on Saturday, October 4th, ... Columbus, Georgia 31904. It will be the first foam and ...
(Date:8/29/2014)... Canada Older adults who stay active by volunteering ... altruistic feeling they are receiving a health boost! ... Rotman Research Institute at Baycrest Health Sciences and published ... the first to take a broad-brush look at all ... of formal volunteering for older adults. , Lead investigator ...
(Date:8/29/2014)... After having a double mastectomy due ... have breast reconstruction. She found that the look of ... that there needed to be a solution. , The ... or man who needs or wants breast improvements. It's ... and peace of mind. Producible in design variations, the ...
(Date:8/29/2014)... August 29, 2014 Honey Gifts, premium ... company will now be selling purse-sized adult toys and ... way that they can be carried in a woman’s ... the purse-sized range at Honey Gifts is also leak-free ... life and rechargeable batteries are common characteristics of Honey ...
(Date:8/29/2014)... 2014 University of Western States (UWS), ... announced that Daniel Redwood, DC, director of the human ... the Year,” by the Missouri State Chiropractors Association (MSCA) ... , Patrick Montgomery, DC, president of the MSCA, cited ... Missouri House Task Force for Medicaid Reform, in bringing ...
Breaking Medicine News(10 mins):Health News:Paint Columbus Pink Cancer Awareness/Kick-Off Meeting for Anyone Interested in Participating 2Health News:Evidence mounting that older adults who volunteer are happier, healthier 2Health News:Honey Gifts Now Provides Purse Sized Adult Toys in Vancouver 2Health News:University of Western States Director of Human Nutrition and Functional Medicine Daniel Redwood, DC, named Missouri Educator of the Year by MSCA 2
... Dec. 1 America,s pharmaceutical research companies are testing ... related conditions, according to a report released today by the ... marks the 20th anniversary of "World AIDS Day" - a ... of Ministers of Health on Programmes for AIDS Prevention. , ...
... Early discussion with your orthopaedic surgeon is the driving force ... , ROSEMONT, Ill., Dec. 1 /PRNewswire-USNewswire/ ... any musculoskeletal injury may be anxious to get back into ... the wheel of a car can be a difficult and ...
... Deadline Is December 31st , , ... D annual enrollment period is nearly halfway over - running from ... is an opportunity for seniors to change the prescription drug program ... in a Part D plan to enroll. , ...
... Unmet Needs for HIV Prevention, Calls on Governments to Increase ... (Para tener acceso a una copia completa de ... , , WASHINGTON, Dec. 1 ... women and Latina women in the United States is demanding ...
... 1, 2008 -- 11 a.m. news event -- Hall of ... DC 20001 , , WASHINGTON, ... coming together to outline the current fiscal situation states are ... a recovery package that will spur job growth, support infrastructure ...
... DISCOVERY IN MOLECULAR IMAGING , , ... North America (RSNA) honored Ralph Weissleder, MD, PhD, with its ... one scientist who has made original significant contributions to the ... is Professor at Harvard Medical School , as well ...
Cached Medicine News:Health News:109 Medicines and Vaccines Now in Development for HIV/AIDS 2Health News:109 Medicines and Vaccines Now in Development for HIV/AIDS 3Health News:When to Get Back Behind the Wheel While on the Road to Recovery 2Health News:When to Get Back Behind the Wheel While on the Road to Recovery 3Health News:Radio Interview Opportunity: Important News for Seniors 2Health News:Latin American and U.S. Latina Women Unite to Demand Access to the Female Condom 2Health News:Latin American and U.S. Latina Women Unite to Demand Access to the Female Condom 3Health News:Governors, Legislators Update Current State Fiscal Conditions, Push for Economic Recovery Package from Congress, President-elect 2Health News:VisEn Co-Founder Named Radiologic Society's 'Outstanding Researcher of the Year' 2Health News:VisEn Co-Founder Named Radiologic Society's 'Outstanding Researcher of the Year' 3
(Date:8/28/2014)... , Aug. 28, 2014 /PRNewswire-iReach/ -- CountryFocus: Healthcare, ... (Photo - http://photos.prnewswire.com/prnh/20140828/140879 ... Healthcare, Regulatory and Reimbursement Landscape Poland " an ... trends in the healthcare market and provides insights ... infrastructure. Most importantly, the report provides valuable insights ...
(Date:8/28/2014)... BURLINGTON, Mass. , Aug. 28, 2014  Decision Resources ... will remain constant, at around $7.7 billion by 2023 in ... , Germany , Italy ... United Kingdom and Japan . ... KGaA,s Erbitux will be balanced out by the launch of ...
(Date:8/28/2014)...   Edison Nation Medical , the premier ... for product ideas to improve the health and ... through the 6-month search ( www.EdisonNationMedical.com/Seniors ) will ... healthcare retailers with whom Edison Nation Medical has ... 65 and older. The objective of ...
Breaking Medicine Technology:Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 2Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 3Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 4Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 5The Colorectal Cancer Market Will Remain Steady at $7.7 Billion by 2023, With Biosimilar Erosion Of Key Agents Being Balanced Out By the Launch Of Premium-Priced Therapies 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 3
... RIDGE, N.J. , March 15 Regado Biosciences, ... aptamers with active control agents, announced that Chris Rusconi ... Steven Zelenkofske , DO, FACC, Senior Vice President , Chief ... Cardiology on Monday, March 15, 2010 in ...
... SAN FRANCISCO, Calif. , March 15 Poniard ... on innovative oncology therapies, today announced the sale of 4,229,000 ... Fund, Ltd. for gross proceeds of approximately $6.3 million ... existing committed equity financing facility with Commerce Court.  Poniard intends ...
Cached Medicine Technology:Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010 2Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010 3Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010 4Poniard Pharmaceuticals Announces $6.3 Million Financing 2Poniard Pharmaceuticals Announces $6.3 Million Financing 3Poniard Pharmaceuticals Announces $6.3 Million Financing 4
... RPR kits use carbon particles coated ... which will combine with antibody present ... particles are suspended in a medium ... specific reactions. Positive reactions are shown ...
... The BD Macro-Vue RPR (Rapid ... and Tear-drop Tests are nontreponemal testing ... syphilis described in A Manual of ... in this manual are the most ...
Rapid Plasma Reagin (RPR) set is a non-treponemal flocculation test that is,used for the qualitative and semi-quantitative determination of reagin,antibodies in serum or plasma from persons with syph...
For use as a quality assurance reagent in assays detecting IgG antibody to mumps virus (mumps IgG), IgG antibody to measles (Rubeola) virus (measles IgG) and IgG antibody to varicella zoster virus (V...
Medicine Products: